Endogena
Endogena therapeutics focuses on developing novel treatments for degenerative diseases.
Launch date
Employees
Market cap
-
Enterprise valuation
$80—120m (Dealroom.co estimates Dec 2021.)
Newton Massachusetts (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
$8.0m | Series A | ||
* | $20.0m | Series A | |
| Total Funding | $28.0m | ||
Related Content
Recent News about Endogena
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.